Please login to the form below

Not currently logged in
Email:
Password:

RAPS calls for awards entries

The Regulatory Affairs Professionals Society seeks candidates for its 2011 fellowship and awards programmes as the deadline approaches

The Regulatory Affairs Professionals Society (RAPS) is seeking candidates for the 2011 class of RAPS Fellows and for its annual awards honouring regulatory professionals in the healthcare products sector.

The RAPS Fellows distinction is reserved for senior-level regulatory professionals who demonstrate dedication to, and leadership in, the advancement of the profession. RAPS Awards are given in five categories celebrating a range of accomplishments within the regulatory profession.

Colleagues must submit awards nominations, while Fellows candidates must apply on their own behalf. The deadline for awards nominations and fellows' applications is May 31.

Fellows and awards recipients will be honored during 2011 RAPS: The Regulatory Convergence, in Indianapolis, US, from October 22–26.

More information can be found at www.RAPS.org

10th March 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics